Adamis Pharmaceuticals Corporation logo
Adamis Pharmaceuticals Corporation ADMP

Quartalsbericht 2023-Q3
hinzugefügt 14.11.2023

report update icon

Adamis Pharmaceuticals Corporation Langfristiger Schuldenstrom 2011-2026 | ADMP

Langfristiger Schuldenstrom Jährlich Adamis Pharmaceuticals Corporation

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
343 K 350 K 493 K 440 K - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
493 K 343 K 406 K

Langfristiger Schuldenstrom anderer Aktien in der Arzneimittelhersteller

Name Langfristiger Schuldenstrom Preis % 24h Marktkapitalisierung Land
Aerie Pharmaceuticals Aerie Pharmaceuticals
AERI
4.36 M - - $ 754 M usaUSA
AcelRx Pharmaceuticals AcelRx Pharmaceuticals
ACRX
5.36 M - 7.5 % $ 6.35 M usaUSA
Catalent Catalent
CTLT
13 M - - $ 11.5 B usaUSA
DURECT Corporation DURECT Corporation
DRRX
1.38 M - - $ 50.1 M usaUSA
Canopy Growth Corporation Canopy Growth Corporation
CGC
7.46 M $ 1.1 3.77 % $ 118 M canadaCanada
Endo International plc Endo International plc
ENDP
956 K - - $ 28.9 M irlandaIrlanda
Agile Therapeutics Agile Therapeutics
AGRX
366 K - 10.11 % $ 58.2 M usaUSA
Evoke Pharma Evoke Pharma
EVOK
13.4 K - - $ 36.6 M usaUSA
Alimera Sciences Alimera Sciences
ALIM
634 K - - $ 142 M usaUSA
Evolus Evolus
EOLS
2.53 M $ 5.46 32.2 % $ 352 M usaUSA
Avadel Pharmaceuticals plc Avadel Pharmaceuticals plc
AVDL
582 K - - $ 2.06 B franceFrance
Jupiter Wellness Jupiter Wellness
JUPW
213 K - - $ 33.6 M usaUSA
China Pharma Holdings China Pharma Holdings
CPHI
39.3 K $ 0.57 3.55 % $ 9.95 M chinaChina
Cumberland Pharmaceuticals Cumberland Pharmaceuticals
CPIX
357 K $ 4.58 - $ 64.4 M usaUSA
Calliditas Therapeutics AB (publ) Calliditas Therapeutics AB (publ)
CALT
3.91 M - -0.1 % $ 2.03 B schwedenSchweden
HEXO Corp. HEXO Corp.
HEXO
914 K - 2.45 % $ 38.1 M canadaCanada
Neoleukin Therapeutics Neoleukin Therapeutics
NLTX
2.56 M - - $ 193 M canadaCanada
Aurora Cannabis Aurora Cannabis
ACB
5.38 M $ 3.65 4.89 % $ 86.3 M canadaCanada
Athenex Athenex
ATNX
2.09 M - -23.39 % $ 1.76 M usaUSA
Harrow Health Harrow Health
HROW
887 K $ 39.84 3.2 % $ 1.46 B usaUSA
Emergent BioSolutions Emergent BioSolutions
EBS
3.5 M $ 8.88 -0.34 % $ 455 M usaUSA
ProPhase Labs ProPhase Labs
PRPH
301 K - - $ 5.07 M usaUSA
Assertio Holdings Assertio Holdings
ASRT
928 K $ 11.86 -0.29 % $ 842 M usaUSA
Radius Health Radius Health
RDUS
613 K - - $ 1.42 B usaUSA
Bausch Health Companies Bausch Health Companies
BHC
61 M $ 5.63 -1.66 % $ 2.05 B canadaCanada
Lannett Company Lannett Company
LCI
2.06 M - 1.15 % $ 7.11 M usaUSA
Eagle Pharmaceuticals Eagle Pharmaceuticals
EGRX
1.53 M - -39.89 % $ 27.7 M usaUSA
Organogenesis Holdings Organogenesis Holdings
ORGO
4.27 M $ 2.89 0.7 % $ 381 M usaUSA
OrganiGram Holdings OrganiGram Holdings
OGI
1.03 M $ 1.4 1.85 % $ 402 M canadaCanada
Rockwell Medical Rockwell Medical
RMTI
1.38 M $ 0.89 -1.05 % $ 20.8 M usaUSA
Perrigo Company plc Perrigo Company plc
PRGO
25.7 M $ 11.57 1.62 % $ 1.6 B usaUSA
Sundial Growers Sundial Growers
SNDL
34.3 M $ 1.55 0.98 % $ 3.37 M canadaCanada
Veru Veru
VERU
1.07 M $ 2.56 1.39 % $ 345 M usaUSA
Viatris Viatris
VTRS
80.6 M $ 14.89 -0.03 % $ 17.9 B usaUSA
cbdMD cbdMD
YCBD
98.7 K $ 0.76 -2.68 % $ 3.28 M usaUSA
TherapeuticsMD TherapeuticsMD
TXMD
1.47 M $ 2.3 3.57 % $ 24 M usaUSA
Pacira BioSciences Pacira BioSciences
PCRX
8.89 M $ 22.11 0.05 % $ 1.02 B usaUSA
PetIQ PetIQ
PETQ
7.61 M - 1.64 % $ 400 M usaUSA
OptiNose OptiNose
OPTN
911 K - - $ 1.08 B usaUSA
PLx Pharma PLx Pharma
PLXP
622 K - -27.8 % $ 2.56 M usaUSA
Recro Pharma Recro Pharma
REPH
1.1 M - -4.76 % $ 65.3 M usaUSA
SCYNEXIS SCYNEXIS
SCYX
340 K $ 0.75 -0.27 % $ 35.9 M usaUSA
Solid Biosciences Solid Biosciences
SLDB
1.79 M $ 5.96 0.02 % $ 243 M usaUSA
Sonoma Pharmaceuticals Sonoma Pharmaceuticals
SNOA
58 K $ 2.75 - $ 3.41 M usaUSA
Tricida Tricida
TCDA
2.74 M - - $ 3.25 M usaUSA
Tilray Tilray
TLRY
2.47 M $ 7.53 2.31 % $ 4.65 B canadaCanada
Zynerba Pharmaceuticals Zynerba Pharmaceuticals
ZYNE
215 K - - $ 55.5 M usaUSA